A WHIM satisfactorily addressed

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In this issue of Blood, McDermott et al present the intriguing, clinically relevant, and perhaps unexpected findings for the efficacy and safety of long-term administration of low-dose plerixafor treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.

Original languageEnglish
Pages (from-to)2286-2288
Number of pages3
JournalBlood
Volume123
Issue number15
DOIs
StatePublished - Apr 10 2014

Fingerprint

Blood
Safety
Therapeutics
WHIM syndrome
JM 3100

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

A WHIM satisfactorily addressed. / Broxmeyer, Hal.

In: Blood, Vol. 123, No. 15, 10.04.2014, p. 2286-2288.

Research output: Contribution to journalArticle

Broxmeyer, Hal. / A WHIM satisfactorily addressed. In: Blood. 2014 ; Vol. 123, No. 15. pp. 2286-2288.
@article{cfd1e3638d9c4cd180bc95c2e2279df0,
title = "A WHIM satisfactorily addressed",
abstract = "In this issue of Blood, McDermott et al present the intriguing, clinically relevant, and perhaps unexpected findings for the efficacy and safety of long-term administration of low-dose plerixafor treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.",
author = "Hal Broxmeyer",
year = "2014",
month = "4",
day = "10",
doi = "10.1182/blood-2014-02-557579",
language = "English",
volume = "123",
pages = "2286--2288",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "15",

}

TY - JOUR

T1 - A WHIM satisfactorily addressed

AU - Broxmeyer, Hal

PY - 2014/4/10

Y1 - 2014/4/10

N2 - In this issue of Blood, McDermott et al present the intriguing, clinically relevant, and perhaps unexpected findings for the efficacy and safety of long-term administration of low-dose plerixafor treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.

AB - In this issue of Blood, McDermott et al present the intriguing, clinically relevant, and perhaps unexpected findings for the efficacy and safety of long-term administration of low-dose plerixafor treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.

UR - http://www.scopus.com/inward/record.url?scp=84899101604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899101604&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-02-557579

DO - 10.1182/blood-2014-02-557579

M3 - Article

VL - 123

SP - 2286

EP - 2288

JO - Blood

JF - Blood

SN - 0006-4971

IS - 15

ER -